Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00843024 · ClinicalTrials.gov registry record · Phase 3
Migraine Study in Adolescent Patients
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 589
- Enrollment target
NCT00843024 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 589 participants.
The verdict
NCT00843024, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 589 participants
- Enrollment target
Study Summary
This study was designed to determine how well the combination medication, sumatriptan and naproxen sodium, treats migraine headache in adolescents 12-17 years old
Interventions
- DRUG Placebo
- DRUG Sumatriptan and Naproxen Sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 589 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00843024
The ClinicalTrials.gov registry entry for NCT00843024 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 589 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00843024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00843024 about?
NCT00843024 is a clinical study titled "Migraine Study in Adolescent Patients". This study was designed to determine how well the combination medication, sumatriptan and naproxen sodium, treats migraine headache in adolescents 12-17 years old
What is the current status of trial NCT00843024?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 589 participants. The study started on 2008-12. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00843024?
The interventions under investigation include: Placebo (DRUG), Sumatriptan and Naproxen Sodium (DRUG).
Who is sponsoring clinical trial NCT00843024?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.